Original Research
In their study, Mark L. Zangardi, PharmD, BCOP, and colleagues, demonstrate that clinical pharmacists have an integral role in the review and approval of off-label oncology treatments.
Scott Wirth, PharmD, BCOP, Sandra Cuellar, PharmD, BCOP, Jaime Kimmel, PharmD, BCOP, Lori Wilken, PharmD, BCACP
This pilot study demonstrated that pharmacists in an ambulatory oncology clinic are able to deliver successful tobacco-cessation counseling and interventions for patients with cancer who smoke.
The World Health Organization’s pain ladder for cancer recommends opioids for the treatment of moderate-to-severe pain in patients with cancer, and is a mainstay of cancer pain therapy.
Elizabeth R. Pritchard, PharmD, BCOP, J. Aubrey Waddell, PharmD, FAPhA, BCOP, Brad J. Crane, PharmD, BCPS, Amy M. Porter, PharmD, Susan Roberts, PharmD, Danielle M. Yates, PharmD, Angelia M. Thomas, MT (ASCP)
Drug containers are defined in USP 797 based on the type of the container and the environment in which the container is opened. Vials are further divided into 2 categories: single-dose or multiple-dose.
Oral chemotherapeutic agents have been available for many years, and were traditionally cytotoxic drugs, such as cyclophosphamide, methotrexate, and mercaptopurine. In recent years, oral anticancer medications are being used more often in many types of cancer.
It is well-known that patients with acute myeloid leukemia (AML) who receive induction and reinduction chemotherapy and any patients undergoing hematopoietic stem-cell transplant (HSCT) are at high risk for infections and prolonged hospital stays. Intensive chemotherapy regimens used in these settings cause patients to be neutropenic for prolonged durations.
Pain is one of the most feared symptoms of cancer, with uncontrolled pain being the most frequently reported symptom in hospitalized patients with cancer. As cancer stage progresses, the pain intensity and incidence increase, with cancer pain reported in 62% to 86% of patients with advanced disease.
Pharmacists are becoming increasingly involved in cancer care. This raises a vital question: How aware are pharmacy students of the expanding roles and opportunities in oncology pharmacy?
The paradigm of oncology practice has changed significantly in recent years with the rapid emergence and use of oral chemotherapy agents.
Anastasia Finn, PharmD, MBA, BCOP, Jesse Young, PharmD, Kathy Edwards, PharmD, BCPS, BCOP, Andy Perez, PharmD, BCOP, Shawn MacVane, PharmD, BCPS
Treatment of Clostridium difficile infection presents a unique challenge in patients with cancer. C difficile infections are often related to the use of antibiotics and to hospitalizations, and patients undergoing chemotherapy treatment may be at a particularly high risk for infection.